PD10: Prostate Cancer: Staging

Podium Session Moderator(s)

• 

  Edmund Chiong

  National University Hospital, Singapore
• 

  Anthony D'Amico

  Brigham and Women's Hospital
• 

  Samir Taneja, MD (he/him/his)

  NYU Grossman School of Medicine, NYU Langone Health

Presentations:

• 3:30 PM – 3:40 PM CST

  PD10-01: Associations between prostate MRI and genomic testing and treatment intensification among patients with localized prostate cancer
  

  Podium Presenter: Michael Leapman, MD – Yale University Department of Urology
• 3:40 PM – 3:50 PM CST

  PD10-02: Using the Negative predictive value and SUVmax of PSMA PET/CT for avoiding pelvic lymph node dissection with radical prostatectomy
  

  Podium Presenter: Gagan Prakash, DNB – Tata Memorial Hospital
• 3:50 PM – 4:00 PM CST

  PD10-03: Prognostic impact of lymph vessel invasion in radical prostatectomy patients
  

  Podium Presenter: Randi M. Pose, MD – Martini-Klinik
• 4:00 PM – 4:10 PM CST

  PD10-04: SUVmax of the primary prostate lesion on the PSMA PET CT – an indicator of aggressive pathology
  

  Podium Presenter: Gagan Prakash, DNB – Tata Memorial Hospital
• 4:10 PM – 4:20 PM CST

  PD10-05: Development of a microultrasound-Based Nomogram to predict Extracapsular Extension in Patients with Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy
  

  Podium Presenter: Nicola Frego, MD
• 4:20 PM – 4:30 PM CST

  PD10-06: A Nomogram to Predict Lymphnode Involvement in Candidates to Robot-Assisted Radical Prostatectomy with iT3 Prostate Cancer on Preoperative Multiparametric MRI as Unique High-Risk Feature
  

  Podium Presenter: Carlo Bravi, MD
• 4:30 PM – 4:40 PM CST

  PD10-07: Can We Rely on Available Models to Identify Candidates for Extended Pelvic Lymph Node Dissection (ePLND) in Men Staged With PSMA-PET? External Validation of the Briganti Nomograms and Development of a Novel Tool to Identify Optimal Candidates for ePLND
  

  Podium Presenter: Giorgio Gandaglia
• 4:40 PM – 4:50 PM CST

  PD10-08: The Prognostic Impact of Preoperative PSMA-PET on Early Oncological Outcomes in Prostate Cancer Patients Treated with Radical Prostatectomy: Results of a Multi-center Analysis
  

  Podium Presenter: Simone Scuderi
• 4:50 PM – 5:00 PM CST

  PD10-09: A Novel Model Integrating Clinical, mp-MRI, and Epigenomic Features to Predict Lymph Node Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy and Pelvic Lymph Node Dissection
  

  Podium Presenter: Marco Bandini, MD – hospital san raffaele
• 5:00 PM – 5:10 PM CST

  PD10-10: Improving Prediction of Local Stage by PSMA-PET. Development of a Novel Integrated Tool for Extracapsular Extension and Seminal Vesicle Invasion Combining Clinical and Imaging Features in Localized Prostate Cancer
  

  Podium Presenter: Simone Scuderi
• 5:10 PM – 5:20 PM CST

  PD10-11: Distinct Clinical Genomic Variations Among Men with Localized vs Metastatic Prostate Cancer
  

  Podium Presenter: Mohammed Al-Toubat
• 5:20 PM – 5:30 PM CST

  PD10-12: Histopathologic and MRI Correlates of Anterior Index Lesions in Prostate Cancer: Implications for Post-Surgical Oncologic Outcomes
  

  Podium Presenter: Zoe Blake, MD, BA – Urologic Oncology Branch, NCI/NIH